Reviewer's report
Title:Serum pepsinogen levels are valuable markers for the diagnosis of gastric
diseases in Chinese
Version: 1Date:9 October 2013
Reviewer: Marcis Leja
Reviewer's report:
The manuscript entitled „ Serum pepsinogen levels are valuable markers for the
diagnosis of gastric diseases in Chinese” by Xiao-Mei Zhang and colleagues
addresses the role of pepsinogen detection for gastric disease in this particular
population.
The topic is actual, and the major value of the work lies in demonstrating
differences in the lesion detection rates with different cut-off values.
The objectives are clearly defined, the methods are acceptable, and the obtained
data are sound. The obtained results are clearly reported. Further remarks are
addressing few of the issues in suggestions. The authors refer to 20 references
that are in general chosen adequately; however more references, in particular in
respect to the differences in the pepsinogen detection method would be desired.
The writing is acceptable.
However the major draw-back is the relatively small number of patients included
to the study – the results obtained in 248 patients (different gastric disease,
including 82 gastric cancer cases) and 34 healthy controls can be hardly
generizable to a wider population.
Few Major Compulsory Revisions should be considered:
1. Please give description on how chronic atrophic gastritis was diagnosed, i.e.
whether biopsies according to updated Sydney system have been obtained in all
the cases?
2. In the Discussion part, the authors are mentioning different cut-off values for
pepsinogens in Japan and Europe, however do not mention that different
test-systems are generally used in one and the other parts of the world for most
of the studies referring to the above tests (ELISA in Europe and latex
agglutination in Japan). The potential discrepancy between the results obtained
by the above methods has to be discussed (Miki K. and Fujishiro, M. Dig.
Endosc., 2009).
3. The presented data do not allow making conclusions on the value of
pepsinogens in predicting gastric tumors, and these conclusions have to be
reformulated.
4. The title of the Table 2 is misleading since does not explain the column
“non-GC group”. i.e. how could be the accuracy for gastric cancer detection be
estimated in the group without any cancer?
In addition, the Discretionary Revisions include the following:
5. The test-type used should be mentioned also in the abstract
6. Additional references have to be added to the Background (e.g. when 5-year
survival is discussed)
7. The suggested cut-off (6.0 for Pg I/II) substantially differs from the cut-off
values suggested in the previous studies. This should be discussed, also by
separating data originating from Asia and Europe.
8. The relation of Pg results to H.pylori in the studied groups should be desirably
discussed; at least the prevalence of the infection in the groups should be
demonstrated.
The minor essential revisions include:
9. An error is present with showing the temperature identification in the
paragraph entitled “Determination of serum PG levels” (-20#C).
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
I declare that I have no competing interests
Reviewer's report
Title:Serum pepsinogen levels are valuable markers for the diagnosis of gastric
diseases in Chinese
Version: 1Date:9 October 2013
Reviewer: Marcis Leja
Reviewer's report:
The manuscript entitled „ Serum pepsinogen levels are valuable markers for the
diagnosis of gastric diseases in Chinese” by Xiao-Mei Zhang and colleagues
addresses the role of pepsinogen detection for gastric disease in this particular
population.
The topic is actual, and the major value of the work lies in demonstrating
differences in the lesion detection rates with different cut-off values.
The objectives are clearly defined, the methods are acceptable, and the obtained
data are sound. The obtained results are clearly reported. Further remarks are
addressing few of the issues in suggestions. The authors refer to 20 references
that are in general chosen adequately; however more references, in particular in
respect to the differences in the pepsinogen detection method would be desired.
The writing is acceptable.
However the major draw-back is the relatively small number of patients included
to the study – the results obtained in 248 patients (different gastric disease,
including 82 gastric cancer cases) and 34 healthy controls can be hardly
generizable to a wider population.
Few Major Compulsory Revisions should be considered:
1. Please give description on how chronic atrophic gastritis was diagnosed, i.e.
whether biopsies according to updated Sydney system have been obtained in all
the cases?
2. In the Discussion part, the authors are mentioning different cut-off values for
pepsinogens in Japan and Europe, however do not mention that different
test-systems are generally used in one and the other parts of the world for most
of the studies referring to the above tests (ELISA in Europe and latex
agglutination in Japan). The potential discrepancy between the results obtained
by the above methods has to be discussed (Miki K. and Fujishiro, M. Dig.
Endosc., 2009).
3. The presented data do not allow making conclusions on the value of
pepsinogens in predicting gastric tumors, and these conclusions have to be
reformulated.
4. The title of the Table 2 is misleading since does not explain the column
“non-GC group”. i.e. how could be the accuracy for gastric cancer detection be
estimated in the group without any cancer?
In addition, the Discretionary Revisions include the following:
5. The test-type used should be mentioned also in the abstract
6. Additional references have to be added to the Background (e.g. when 5-year
survival is discussed)
7. The suggested cut-off (6.0 for Pg I/II) substantially differs from the cut-off
values suggested in the previous studies. This should be discussed, also by
separating data originating from Asia and Europe.
8. The relation of Pg results to H.pylori in the studied groups should be desirably
discussed; at least the prevalence of the infection in the groups should be
demonstrated.
The minor essential revisions include:
9. An error is present with showing the temperature identification in the
paragraph entitled “Determination of serum PG levels” (-20#C).
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
I declare that I have no competing interests
Please review this paper.
user
Reviewer's report
Title:Serum pepsinogen levels are valuable markers for the diagnosis of gastric
diseases in Chinese
Version: 1Date:9 October 2013
Reviewer: Marcis Leja
Reviewer's report:
The manuscript entitled „ Serum pepsinogen levels are valuable markers for the
diagnosis of gastric diseases in Chinese” by Xiao-Mei Zhang and colleagues
addresses the role of pepsinogen detection for gastric disease in this particular
population.
The topic is actual, and the major value of the work lies in demonstrating
differences in the lesion detection rates with different cut-off values.
The objectives are clearly defined, the methods are acceptable, and the obtained
data are sound. The obtained results are clearly reported. Further remarks are
addressing few of the issues in suggestions. The authors refer to 20 references
that are in general chosen adequately; however more references, in particular in
respect to the differences in the pepsinogen detection method would be desired.
The writing is acceptable.
However the major draw-back is the relatively small number of patients included
to the study – the results obtained in 248 patients (different gastric disease,
including 82 gastric cancer cases) and 34 healthy controls can be hardly
generizable to a wider population.
Few Major Compulsory Revisions should be considered:
1. Please give description on how chronic atrophic gastritis was diagnosed, i.e.
whether biopsies according to updated Sydney system have been obtained in all
the cases?
2. In the Discussion part, the authors are mentioning different cut-off values for
pepsinogens in Japan and Europe, however do not mention that different
test-systems are generally used in one and the other parts of the world for most
of the studies referring to the above tests (ELISA in Europe and latex
agglutination in Japan). The potential discrepancy between the results obtained
by the above methods has to be discussed (Miki K. and Fujishiro, M. Dig.
Endosc., 2009).
3. The presented data do not allow making conclusions on the value of
pepsinogens in predicting gastric tumors, and these conclusions have to be
reformulated.
4. The title of the Table 2 is misleading since does not explain the column
“non-GC group”. i.e. how could be the accuracy for gastric cancer detection be
estimated in the group without any cancer?
In addition, the Discretionary Revisions include the following:
5. The test-type used should be mentioned also in the abstract
6. Additional references have to be added to the Background (e.g. when 5-year
survival is discussed)
7. The suggested cut-off (6.0 for Pg I/II) substantially differs from the cut-off
values suggested in the previous studies. This should be discussed, also by
separating data originating from Asia and Europe.
8. The relation of Pg results to H.pylori in the studied groups should be desirably
discussed; at least the prevalence of the infection in the groups should be
demonstrated.
The minor essential revisions include:
9. An error is present with showing the temperature identification in the
paragraph entitled “Determination of serum PG levels” (-20#C).
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
I declare that I have no competing interests
assistant